Normal view MARC view ISBD view

[Development of higher nerve activity and the education of small children]. [electronic resource]

By:

STSCHELOWANOW, N M

Producer: 20020501Description: 777-82 p. digitalISSN:

0044-2178

Subject(s):

In: Zeitschrift fur arztliche Fortbildung vol. 50

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

16781 Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
by Cohen, B J
16782 Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus.
by Chiu, Fang-Feng
16783 Avidin fusion protein-expressing lentiviral vector for targeted drug delivery.
by Lesch, Hanna P
16784 Vaccination against porcine parvovirus protects against disease, but does not prevent infection and virus shedding after challenge infection with a heterologous virus strain.
by Jóźwik, A
16785 Neutralization efficiency is greatly enhanced by bivalent binding of an antibody to epitopes in the V4 region and the membrane-proximal external region within one trimer of human immunodeficiency virus type 1 glycoproteins.
by Wang, Pengcheng
16786 A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome.
by Handisurya, Alessandra
16787 Response to a monovalent 2009 influenza A (H1N1) vaccine.
by Greenberg, Michael E
16788 Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus.
by Kohlmann, Rebekka
16789 [Coxsackie virus].
by Kaji, Masahide
16790 Serological and virological studies of Newcastle disease and avian influenza in slaughter-age ostriches (Struthio camelus) in Japan.
by Sakai, Kouji
16791 A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus.
by Hunt, Ann R
16792 Therapeutic control of hepatitis C virus: the role of neutralizing monoclonal antibodies.
by Keck, Z Y
16793 High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization.
by Hu, Qinxue
16794 Dissecting the humoral immune response to simian immunodeficiency virus: mechanisms of antibody-mediated virus neutralization.
by Steckbeck, Jonathan D
16795 Flavivirus serology by Western blot analysis.
by Oceguera, Leopoldo F
16796 The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.
by Karlsson Hedestam, Gunilla B
16797 Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection.
by Gerna, Giuseppe
16798 Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.
by Montefiori, David C
16799 Truncated E2 of bovine viral diarrhea virus (BVDV) expressed in Drosophila melanogaster cells: a candidate antigen for a BVDV ELISA.
by Marzocca, M P
16800 [Effect of 2-phenoxyethanol on potency of Sabin inactivated poliomyelitis vaccine and its safety].
by Bian, Chuan-xiu